Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial
Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange Detected- Added a funding/status notice and operating details for NIH Clinical Center, plus a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%
- Check21 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' option was removed.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific facility names and locations in the Île-de-France region, while also removing several related terms and previous location details.SummaryDifference7%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.